Collaborating with academia and industry
The Friedrich Miescher Institute for Biomedical Research maintains an active and productive network with its scientific partners in academia and industry.
Translation into biomedical application with industry
Through its excellent interactions with Novartis, the FMI has extensive experience in the translation of its research findings into biomedical application. The FMI has over 50 collaborations with Novartis colleagues at
Novartis Institutes of BioMedical Research (NIBR) and within the
Genomics Institute of the Novartis Research Foundation - GNF, the
Novartis Institute for Tropical Diseases - NITD, and the
Novartis Vaccines Institute for Global Health - NVGH.
The FMI applies a patent policy based on industry standards. Novartis Pharma AG has first right of refusal on IP originating from the FMI. However, there are often findings that Novartis chooses not to pursue and these are available for anyone to exploit.
Vibrant interactions with academia
Within the greater Basel area, the FMI interacts energetically with academic counterparts at the
» Biozentrum of the University of Basel
» Department of Biosystems Science and Engineering of the ETH Zürich
» Swiss Tropical and Public Health Institute
» Department of Biomedicine of the University of Basel
In addition, scientists from the FMI cultivate contacts in and contribute to national and international competency networks:
» Swiss Institute of Bioinformatics
» Swiss Nanoscience Institute
» National Science Foundation
» NCCR Frontiers in Genetics
» NCCR Synapsy